UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 11, 2003
HEMACARE CORPORATION
(Exact Name of Registrant as Specified in its Charter)
CALIFORNIA
(State or other jurisdiction of incorporation)
000-15223 95-3280412
(Commission File No.) (IRS Employer Identification No.)
21101 Oxnard Street
Woodland Hills, CA 91367
(Address of principal executive offices and Zip Code)
Registrant's telephone number, including area code: (818) 226-1968
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
Exhibit Number Description
-------------- -----------------------------------------------
99.1 Press Release issued by HemaCare, dated
August 11, 2003
99.2 Transcript of presentation given by Judi Irving
at a conference call conducted by HemaCare
Corporation on August 11, 2003
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On August 11, 2003, HemaCare Corporation issued a press release
announcing financial results for the second quarter of 2003. A
copy is attached as Exhibit 99.1 to this report and is
incorporated herein by reference.
On August 11, 2003, HemaCare Corporation will hold an investor
conference call to discuss the financial results for the second
quarter of 2003. A transcript of the presentation given by Ms.
Judi Irving in the call is attached to this report as Exhibit
99.2 and is incorporated herein by reference.
The information in this Current Report on Form 8-K, including
the exhibits, will not be treated as "filed" for the purposes of
Section 18 of the Securities and Exchange Act of 1934 (the
"Exchange Act") or otherwise subject to the liabilities of that
section. This information will not be incorporated by reference
into a filing under the Securities Act of 1933, or into another
filing under the Exchange Act, unless that filing expressly
refers to specific information in this report.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
Date: August 11, 2003 HEMACARE CORPORATION
/s/ Judi Irving
-------------------------
Judi Irving,
Chief Executive Officer
EXHIBIT INDEX
Exhibit Number Description
-------------- -----------------------------------------------
99.1 Press Release issued by HemaCare, dated
August 11, 2003
99.2 Transcript of presentation given by Judi Irving
at a conference call conducted by HemaCare
Corporation on August 11, 2003